[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370622-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370622-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","gsdmd-is-a-novel-predictive-biomarker-for-immunotherapy-response-in-the-pan-cancer-and-single-cell-landscapes","GSDMD is a novel predictive biomarker for immunotherapy response - in the pan-cancer and single cell landscapes","","GSDMD, an executor of pyroptosis, is linked to remodeling the tumor immune microenvironment, yet its value as a predictive biomarker for immunotherapy response remains unresolved. Using pan-cancer expression analyses across TCGA cohorts, the study evaluates associations between GSDMD and TMB, MSI, MMR, immune infiltration, and immune checkpoint signatures. Single-cell RNA sequencing characterizes GSDMD-related immune pathways, and organoid functional assays show PARP inhibitor–mediated antitumor effects partly rely on enhancing GSDMD-driven pyroptosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/gsdmd-is-a-novel-predictive-biomarker-for-immunotherapy-response-in-the-pan-cancer-and-single-cell-landscapes/370622/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/gsdmd-is-a-novel-predictive-biomarker-for-immunotherapy-response-in-the-pan-cancer-and-single-cell-landscapes/370622.png","ImageObject",300,407,{"name":42,"@type":43},"Fahsai","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is GSDMD investigated as a predictive biomarker for immunotherapy response?","Question",{"text":63,"@type":64},"GSDMD is a key mediator of pyroptosis and is implicated in modulating the tumor immune microenvironment, but its predictive role for immunotherapy response was unclear.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was GSDMD evaluated across cancers in this study?",{"text":68,"@type":64},"The study performed pan-cancer analyses of GSDMD expression across TCGA datasets and assessed its relationship with TMB, MSI, MMR status, immune infiltration, and immune checkpoint gene signatures.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence connects GSDMD to PARP inhibitor effects in organoids?",{"text":72,"@type":64},"Organoid-based functional assays confirmed that PARP inhibitors exert antitumor effects at least partly by enhancing GSDMD-mediated pyroptosis, and GSDMD expression influenced PARPi sensitivity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370622,1790218070,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","TYPE Original Research PUBLISHED 26 May 2025  \nDOI 10.3389/fimmu.2025.1570901  \nOPEN ACCESS  \nEDITED BY  \nNan-Shan Chang,  \nChina Medical University, Taiwan  \nREVIEWED BY  \nSenlin Ji,  \nNanjing Drum Tower Hospital, China Hao Wang,  \nYunnan Agricultural University, China  \n*CORRESPONDENCE  \nYe Yang  \n[ye.yang@shgh.cn](ye.yang@shgh.cn)[ ](ye.yang@shgh.cn)Qin Yi Zhang  \n [zhangqinyi@sjtu.edu.cn](zhangqinyi@sjtu.edu.cn)[ ](zhangqinyi@sjtu.edu.cn)Jiang Dong Xiang  \n [xjd13818757959@126.com](xjd13818757959@126.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \n‡These authors have contributed equally to this work  \nRECEIVED 04 February 2025  \nACCEPTED 05 May 2025  \nPUBLISHED 26 May 2025  \nCITATION  \nHuang LJ, Chen F, Chen L, Zhan ST, Liu MM, Xiang JD, Zhang QY and Yang Y (2025) GSDMD is a novel predictive biomarker for immunotherapy response: in the pan-cancer and single cell landscapes.  \nFront. Immunol. 16:1570901 .  \ndoi: 10.3389/fimmu.2025.1570901  \nCOPYRIGHT  \n© 2025 Huang, Chen, Chen, Zhan, Liu, Xiang, Zhang and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nGSDMD is a novel predictive biomarker for immunotherapy response: in the pan-cancer and single cell landscapes  \nLi Juan Huang †, Feng Chen †, Lin Chen, Shi Tong Zhan, Ming Min Liu, Jiang Dong Xiang*‡, Qin Yi Zhang*‡ and Ye Yang *‡  \nObstetrics and Gynecology Department, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China  \nBackground: Gasdermin D (GSDMD), a key executor of pyroptosis, has been implicated in modulating the tumor immune microenvironment. However, its role as a predictive biomarker for immunotherapy response remains unclear.  \nMethods: We conducted a pan-cancer analysis of GSDMD expression across TCGA datasets and investigated its association with tumor mutational burden (TMB), microsatellite instability (MSI), and mismatch repair (MMR) status. Immunological relevance was further assessed by correlating GSDMD expression with immune cell inﬁltration and immune checkpoint gene signatures. We performed single-cell RNA sequencing analysis to investigate the immune cell populations and immunological pathways associated with GSDMD expression. Finally, organoid-based functional assays conﬁrmed that Poly ADP-ribose polymerase inhibitors (PARPi) exert antitumor effects at least in part by enhancing GSDMD-mediated pyroptosis.  \nResults: GSDMD was found to be aberrantly expressed in multiple tumor types and positively correlated with TMB, MSI, and immune checkpoint expression. High GSDMD expression was associated with increased inﬁltration of proinﬂammatory immune cells. In organoid models, GSDMD expression inﬂuenced sensitivity to PARPi, suggesting a potential role in shaping the immune-responsive phenotype.  \nConclusion: Our ﬁndings highlight GSDMD as a potential biomarker for predicting immunotherapy response and as a modulator of tumor-immune interactions. These results provide a foundation for future studies exploring GSDMD-targeted strategies to enhance immunotherapeutic efﬁcacy.  \nKEYWORDS  \npan-cancer, pyroptosis, GSDMD, immunotherapy, prognosis  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nCancer treatment has long been complicated by tumor heterogeneity, treatment resistance, and the persistent challenges of recurrence and metastasis (1 , 2) . Traditional therapeutic approaches often fail to adequately address these complexities, underscoring the urgent need to identify new treatment targetsand strategies to enhance the effectiveness of cancer th","cbCaikn2wl637DiL","https://ap.wps.com/l/cbCaikn2wl637DiL","pdf",8614000,16,"English","# Introduction\n## Background and rationale\n# Methods\n## Pan-cancer analysis and immune profiling\n## Single-cell RNA sequencing\n## Organoid functional assays\n# Results\n## GSDMD expression patterns and correlations\n## Immune infiltration and checkpoint associations\n## Sensitivity to PARP inhibitors in organoid models\n# Conclusion\n## Potential biomarker and therapeutic implications","[{\"question\":\"Why is GSDMD investigated as a predictive biomarker for immunotherapy response?\",\"answer\":\"GSDMD is a key mediator of pyroptosis and is implicated in modulating the tumor immune microenvironment, but its predictive role for immunotherapy response was unclear.\"},{\"question\":\"How was GSDMD evaluated across cancers in this study?\",\"answer\":\"The study performed pan-cancer analyses of GSDMD expression across TCGA datasets and assessed its relationship with TMB, MSI, MMR status, immune infiltration, and immune checkpoint gene signatures.\"},{\"question\":\"What evidence connects GSDMD to PARP inhibitor effects in organoids?\",\"answer\":\"Organoid-based functional assays confirmed that PARP inhibitors exert antitumor effects at least partly by enhancing GSDMD-mediated pyroptosis, and GSDMD expression influenced PARPi sensitivity.\"}]","GSDMD is a novel predictive biomarker for immunotherapy response - in the pan-cancer and single cell landscapes | PDF",1790189504,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ffac904be8e1253008bf6120ca5dad1.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/facd32d5d6bc2d95822ec9d977da2afe.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f79e39c730bd54d7f7e6227f1c4eb9a9.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/435be87ca30a180962d7c9aa30006de5.webp",980,1385]